ADIM
DVAX

Alpha DNA Investment Management’s Dynavax Technologies DVAX Stock Holding History

Alpha DNA Investment Management’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-40,134
Closed -$593K – 203
2023
Q3 		$593K Buy
+40,134
New +$564K 0.24% 88
2022
Q1 		– Sell
-105,910
Closed -$1.49M – 128
2021
Q4 		$1.49M Buy
+105,910
New +$1.74M 0.94% 78

Other funds holding DVAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Alpha DNA Investment Management's DVAX Position: Q4 2023 in Review

Alpha DNA Investment Management sold out of Dynavax Technologies (DVAX) in Q4 2023, closing a stake of 40,134 shares — an estimated $593K sold.

Alpha DNA Investment Management first reported a position in DVAX in Q4 2021 and held it in 2 quarters. The position peaked at $1.49M in Q4 2021. 246 funds tracked by Wall St. Rank hold DVAX as of Q4 2023.

  • Alpha DNA Investment Management reported no remaining Dynavax Technologies position as of Q4 2023 after selling out during the quarter.
  • Alpha DNA Investment Management sold 40,134 Dynavax Technologies shares in Q4 2023, an estimated $593K.
  • Alpha DNA Investment Management first reported a position in Dynavax Technologies in Q4 2021 and held it in 2 quarters.
  • Alpha DNA Investment Management's Dynavax Technologies position peaked at $1.49M in Q4 2021.
  • 246 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2023.

Based on Alpha DNA Investment Management's 13F filing for Q4 2023, filed 12 Feb 2024.